Skip to main content
Have a personal or library account? Click to login
EDTA/glycine-acid versus chloroquine diphosphate treatment for stripping Bg antigens from red blood cells Cover

EDTA/glycine-acid versus chloroquine diphosphate treatment for stripping Bg antigens from red blood cells

Immunohematology
Volume 15 (1999): Issue 2 (June 1999)
By: ,  ,  ,   and    
Paid access
|Oct 2020
Authors

Authors

K. Champagne

Consultation and Education, Gamma Biologicals, Subsidiary of Immucor, Houston, USA

P. Spruell

Gamma Biologicals, Subsidiary of Immucor, Houston, USA

J. Chen

Gamma Biologicals, Subsidiary of Immucor, Houston, USA

L. Voll

Gamma Biologicals, Subsidiary of Immucor, Houston, USA

G. Schlanser

Gamma Biologicals, Subsidiary of Immucor, Houston, USA
DOI: https://doi.org/10.21307/immunohematology-2019-615 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Journal RSS Feed
Language: English
Page range: 66 - 68
Published on: Oct 26, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
EDTA/glycine-acid (EGA) treatment chloroquine diphosphate (CDP) treatment,
Bg antigens,
Bg antibodies,
indirect antiglobulin test (IAT)
Related subjects:
Medicine,
Clinical medicine,
Laboratory medicine

© 2020 K. Champagne, P. Spruell, J. Chen, L. Voll, G. Schlanser, published by American National Red Cross
This work is licensed under the Creative Commons License.

Volume 15 (1999): Issue 2 (June 1999)
Previous article
Next article